Unfortunately, this book can't be printed from the OpenBook. Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
The successes seen in a number of clinical studies on viral vector-based gene therapies (AAV, retroviral, and lentiviral vectors) are well documented, with an ever-broadening pipeline of products ...
SAN FRANCISCO, CA—A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. The approach, developed at Gladstone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results